AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Dec 10, 2025
31676_dirs_2025-12-09_dffa61b7-363f-493a-8184-4b71ef4d1f5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-12-05
Reporting Person: TANNENBAUM RENEE P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | Common Stock | S | 1800 | $81.15 | Disposed | 25157 | Direct |
Footnotes
F1: The shares were sold in multiple trades at prices ranging from $81.14 to $81.16. The price reported above reflects the weighted average sales price.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3